Immutep
IMMP
8 hedge funds and large institutions have $220K invested in Immutep in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% less funds holding
Funds holding: 12 → 8 (-4)
36% less capital invested
Capital invested by funds: $346K → $220K (-$126K)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$108K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$37.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.9K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FNYS
First New York Securities
New York
|
-$134K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$57K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$51.5K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$46K |
IMMP Hedge Fund Activity: Q2 2016 in Review
8 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2016, worth a combined $220K — down 36% from $346K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of IMMP and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $108K. The largest seller was First New York Securities, exiting entirely with an estimated $134K sold.
- 8 institutional investors held Immutep (IMMP) as of Q2 2016, down from 12 in Q1 2016.
- Funds reported $220K of Immutep stock for Q2 2016, down 36% quarter-over-quarter.
- 2 funds opened new Immutep positions in Q2 2016 and 6 closed out, a net change of -4 holders.
- The largest Immutep buyer in Q2 2016 was UBS Group, an estimated $108K added.
- The largest Immutep seller in Q2 2016 was First New York Securities, an estimated $134K sold.
Based on aggregated 13F filings for Q2 2016.